{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:52:43Z","timestamp":1791067963316,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["NO. LHDMZ26H030002"],"award-info":[{"award-number":["NO. LHDMZ26H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82574893"],"award-info":[{"award-number":["NO. 82574893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158832","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:20:22Z","timestamp":1790688022000},"page":"158832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting renal lipotoxicity with natural products in chronic kidney disease: mechanisms, molecular targets, and translational prospects"],"prefix":"10.1016","volume":"162","author":[{"given":"Yiming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luowen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jike","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-0428","authenticated-orcid":false,"given":"Changyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0001","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","article-title":"Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression","volume":"56","author":"Abedini","year":"2024","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.phymed.2026.158832_bib0002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2024.12.004","article-title":"NAD(+) metabolism in acute kidney injury and chronic kidney disease transition","volume":"31","author":"Alhumaidi","year":"2025","journal-title":"Trends. Mol. Med."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharmaceutic."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Disc."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","article-title":"Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease","volume":"18","author":"Baek","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"9784","key":"10.1016\/j.phymed.2026.158832_bib0006","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316615","article-title":"Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy","volume":"20","author":"Bao","year":"2025","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","article-title":"Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney","volume":"19","author":"Bay\u0131r","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-025-00938-1","article-title":"Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease","volume":"21","author":"Byun","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phymed.2026.158832_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.769213","article-title":"Mfn2 Regulates high glucose-induced MAMs dysfunction and apoptosis in podocytes via PERK pathway","volume":"9","author":"Cao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158832_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18134","article-title":"Proteomics reveals defective peroxisomal fatty acid oxidation during the progression of acute kidney injury and repair","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phymed.2026.158832_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112560","article-title":"Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: a network pharmacology, molecular docking and experimental validation study","volume":"138","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2026.158832_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118156","article-title":"Hydrangea paniculata coumarins alleviate adriamycin-induced renal lipotoxicity through activating AMPK and inhibiting C\/ebp\u03b2","volume":"329","author":"Chen","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158832_bib0014","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s12272-024-01521-1","article-title":"Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment","volume":"47","author":"Chen","year":"2024","journal-title":"Arch. Pharm. Res."},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0015","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41419-020-03199-x","article-title":"Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41401-021-00660-1","article-title":"Druggability of lipid metabolism modulation against renal fibrosis","volume":"43","author":"Chen","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.phymed.2026.158832_bib0017","doi-asserted-by":"crossref","DOI":"10.7326\/M16-2977","article-title":"CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (traditional Chinese version)","volume":"167","author":"Cheng","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0018","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000486398","article-title":"Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from Bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study","volume":"47","author":"Chin","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0019","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.phymed.2026.158832_bib0020","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1681\/ASN.2020060806","article-title":"Kidney single-cell atlas reveals myeloid heterogeneity in progression and regression of Kidney disease","volume":"31","author":"Conway","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phymed.2026.158832_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.618322","article-title":"Two types of contact between lipid droplets and mitochondria","volume":"8","author":"Cui","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0022","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s42003-023-05272-5","article-title":"Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease","volume":"6","author":"Dai","year":"2023","journal-title":"Commun. Biol."},{"issue":"26","key":"10.1016\/j.phymed.2026.158832_bib0023","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0024","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","article-title":"NAD(+) precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury","volume":"5","author":"Doke","year":"2023","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","article-title":"The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development","volume":"32","author":"Doke","year":"2022","journal-title":"Trends. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158832_bib0026","article-title":"Fisetin attenuates diabetic nephropathy-induced podocyte injury by inhibiting NLRP3 inflammasome","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158832_bib0027","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fphar.2020.00265","article-title":"Recent insights into SREBP as a direct mediator of kidney fibrosis via lipid-independent pathways","volume":"11","author":"Dorotea","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0028","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2338933","article-title":"TXNIP deficiency attenuates renal fibrosis by modulating mTORC1\/TFEB-mediated autophagy in diabetic kidney disease","volume":"46","author":"Du","year":"2024","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0029","doi-asserted-by":"crossref","first-page":"184","DOI":"10.31083\/j.fbl2706184","article-title":"PINK1\/Parkin-mediated mitophagy plays a protective role in albumin overload-induced renal tubular cell injury","volume":"27","author":"Duan","year":"2022","journal-title":"Front. Biosci."},{"issue":"12","key":"10.1016\/j.phymed.2026.158832_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","article-title":"Crosstalk between lipids and mitochondria in diabetic kidney disease","volume":"19","author":"Ducasa","year":"2019","journal-title":"Curr. Diab. Rep."},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0031","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0032","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.chembiol.2025.02.003","article-title":"Mechanisms and functions of lysosomal lipid homeostasis","volume":"32","author":"Ebner","year":"2025","journal-title":"Cell Chem. Biol."},{"issue":"18","key":"10.1016\/j.phymed.2026.158832_bib0033","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/cvr\/cvad190","article-title":"The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease","volume":"119","author":"Elwakiel","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0034","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.7150\/ijbs.114907","article-title":"Mesangial cells in diabetic kidney disease: from mechanisms to therapeutic implications","volume":"21","author":"Feng","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0035","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0036","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169607","article-title":"Renal proximal tubule cells: power and finesse","volume":"133","author":"Fuchs","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0037","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","article-title":"Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement","volume":"144","author":"Gagnier","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.phymed.2026.158832_bib0038","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1172\/JCI127277","article-title":"Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice","volume":"129","author":"Galvan","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2026.158832_bib0039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41581-025-01028-y","article-title":"The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease","volume":"22","author":"Gamez","year":"2026","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phymed.2026.158832_bib0040","article-title":"Fatty acid \u03b2-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0041","doi-asserted-by":"crossref","first-page":"F444","DOI":"10.1152\/ajprenal.00168.2025","article-title":"Fatty acids and albumin are transported by distinct mechanisms in the proximal tubule","volume":"329","author":"Garcia","year":"2025","journal-title":"Am J Physiol Ren. Physiol."},{"issue":"10518","key":"10.1016\/j.phymed.2026.158832_bib0042","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158832_bib0043","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fphys.2020.00732","article-title":"The vicious cycle of renal lipotoxicity and mitochondrial dysfunction","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0044","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/biomedicines13061424","article-title":"Pathogenesis and therapeutic perspectives of tubular injury in diabetic kidney disease: an update","volume":"13","author":"Geng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phymed.2026.158832_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118615","article-title":"The dual role of lipids in chronic kidney disease: pathogenic culprits and therapeutic allies","volume":"398","author":"Giardini","year":"2024","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.phymed.2026.158832_bib0046","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2215\/CJN.0000000000000337","article-title":"Effect of resveratrol on endothelial function in patients with CKD and Diabetes: a randomized controlled trial","volume":"19","author":"Gimblet","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0047","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/antiox13080983","article-title":"Curcumin supplementation and vascular and cognitive function in chronic kidney disease: a randomized controlled trial","volume":"13","author":"Gimblet","year":"2024","journal-title":"Antioxidant"},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151582","article-title":"Spatial metabolomics and lipidomics in kidney disease","volume":"44","author":"Gorman","year":"2024","journal-title":"Semin. Nephrol."},{"issue":"23","key":"10.1016\/j.phymed.2026.158832_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311637","article-title":"Natural products as potential therapeutic candidates for diabetic kidney disease: molecular mechanisms, translational challenges, and future prospects","volume":"26","author":"Guo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12964-023-01399-4","article-title":"ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease","volume":"22","author":"Hao","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phymed.2026.158832_bib0051","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jconrel.2022.06.029","article-title":"Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy","volume":"348","author":"He","year":"2022","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.phymed.2026.158832_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.953205","article-title":"Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research-the ConPhyMP-guidelines","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158832_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122813","article-title":"NLRP3 Inflammasome: a central player in renal pathologies and nephropathy","volume":"351","author":"Henedak","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0054","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.kint.2020.02.041","article-title":"The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?","volume":"98","author":"Hesp","year":"2020","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0056","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","article-title":"Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney","volume":"81","author":"Hou","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122722","article-title":"Blockade of STARD3-mediated cholesterol transport alleviates diabetes-induced podocyte injury by reducing mitochondrial cholesterol accumulation","volume":"349","author":"Hu","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0058","doi-asserted-by":"crossref","DOI":"10.1515\/med-2024-0918","article-title":"CD36-mediated podocyte lipotoxicity promotes foot process effacement","volume":"19","author":"Hua","year":"2024","journal-title":"Open. Med."},{"key":"10.1016\/j.phymed.2026.158832_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175953","article-title":"Liver X receptors: from pharmacology to nanoparticle-based drug delivery","volume":"956","author":"Hua","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0060","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1080\/21655979.2022.2045834","article-title":"Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)","volume":"13","author":"Huang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.phymed.2026.158832_bib0061","article-title":"Natural products for kidney disease treatment: focus on targeting mitochondrial dysfunction","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158832_bib0062","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmed.2020.00065","article-title":"Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases","volume":"7","author":"Jang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.phymed.2026.158832_bib0063","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.niox.2025.10.001","article-title":"Diabetic nephropathy: role of nitric oxide","volume":"159","author":"Jeddi","year":"2025","journal-title":"Nitric. Oxid."},{"key":"10.1016\/j.phymed.2026.158832_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phymed.2026.158832_bib0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/DMSO.S195456","article-title":"Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy","volume":"Volume 12","author":"Jiang","year":"2019","journal-title":"Diabetes. Metab. Syndr. Obes."},{"key":"10.1016\/j.phymed.2026.158832_bib0066","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","article-title":"Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes","volume":"794","author":"Jin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0067","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181443","article-title":"NAD+ prevents chronic kidney disease by activating renal tubular metabolism","volume":"10","author":"Jones","year":"2025","journal-title":"JCI. Insight."},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0068","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae216","article-title":"Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease","volume":"17","author":"Kajio","year":"2024","journal-title":"Clin. Kidney J."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0069","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.2017030314","article-title":"Kidney proximal tubule lipoapoptosis is regulated by fatty acid transporter-2 (FATP2)","volume":"29","author":"Khan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.phymed.2026.158832_bib0071","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136845","article-title":"Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression","volume":"5","author":"Khan","year":"2020","journal-title":"JCI. Insight."},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0072","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/ptr.7589","article-title":"Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: a comprehensive review","volume":"36","author":"Khoshandam","year":"2022","journal-title":"PhytOther Res."},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0073","doi-asserted-by":"crossref","first-page":"755","DOI":"10.34067\/KID.0006152020","article-title":"Podocyte lipotoxicity in CKD","volume":"2","author":"Kim","year":"2021","journal-title":"Kidney360"},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0074","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","article-title":"Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1\u03b1 axis in db\/db mice","volume":"56","author":"Kim","year":"2013","journal-title":"Diabetologia"},{"issue":"23","key":"10.1016\/j.phymed.2026.158832_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311724","article-title":"Endothelial-to-mesenchymal transition in health and disease: molecular insights and therapeutic implications","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158832_bib0076","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41419-021-03452-x","article-title":"Characterization of ferroptosis in kidney tubular cell death under diabetic conditions","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"7970","key":"10.1016\/j.phymed.2026.158832_bib0077","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0078","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The key role of altered tubule cell lipid metabolism in kidney disease development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0079","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1681\/ASN.2018010050","article-title":"Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of Metformin","volume":"29","author":"Lee","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cmet.2024.02.015","article-title":"Transcriptomic, epigenomic, and spatial metabolomic cell profiling redefines regional human kidney anatomy","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158832_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178155","article-title":"The cGAS-STING axis in kidney disease: mechanisms and therapeutic potential","volume":"1006","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0082","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/CM9.0000000000003022","article-title":"Role of mitochondrial dysfunction in kidney disease: insights from the cGAS-STING signaling pathway","volume":"137","author":"Li","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.phymed.2026.158832_bib0083","article-title":"Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"46","key":"10.1016\/j.phymed.2026.158832_bib0084","first-page":"3756","article-title":"[Effects of berberine on the serum cystatin C levels and urine albumin\/creatine ratio in patients with type 2 diabetes mellitus]","volume":"98","author":"Li","year":"2018","journal-title":"Zhonghua. Yi. Xue. Za. Zhi."},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0085","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.7150\/thno.71722","article-title":"Twist1 downregulation of PGC-1\u03b1 decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0086","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dom.70220","article-title":"Renal lipotoxicity in diabetic and obesity-associated kidney diseases: molecular mechanisms and therapeutic targeting","volume":"28","author":"Liu","year":"2026","journal-title":"Diabetes. Obes. Metab."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0087","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2020.06.040","article-title":"Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome","volume":"98","author":"Liu","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2026.158832_bib0088","first-page":"1","article-title":"Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling","volume":"2017","author":"Lu","year":"2017","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.phymed.2026.158832_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155718","article-title":"Interplay of lipid metabolism and inflammation in podocyte injury","volume":"150","author":"Luo","year":"2024","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0090","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-022-05179-9","article-title":"CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis","volume":"13","author":"Lv","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0091","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140695","article-title":"Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.phymed.2026.158832_bib0092","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.devcel.2023.05.006","article-title":"PLIN5 interacts with FATP4 at membrane contact sites to promote lipid droplet-to-mitochondria fatty acid transport","volume":"58","author":"Miner","year":"2023","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0093","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0094","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","article-title":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease","volume":"33","author":"Mori","year":"2021","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172963","article-title":"ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules","volume":"134","author":"Mukhi","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0096","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/nu13010241","article-title":"Effects of high glucose and lipotoxicity on diabetic podocytes","volume":"13","author":"Nakamichi","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0097","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162498","article-title":"TFEB-mediated lysosomal exocytosis alleviates high-fat diet-induced lipotoxicity in the kidney","volume":"8","author":"Nakamura","year":"2023","journal-title":"JCI. Insight."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0098","doi-asserted-by":"crossref","first-page":"F877","DOI":"10.1152\/ajprenal.00415.2023","article-title":"Mechanisms and implications of podocyte autophagy in chronic kidney disease","volume":"326","author":"Njeim","year":"2024","journal-title":"Am. J. Phys. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0099","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cmet.2025.03.004","article-title":"Gang of 3: how the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation","volume":"37","author":"P\u00e5lsson-McDermott","year":"2025","journal-title":"Cell Metab."},{"issue":"24","key":"10.1016\/j.phymed.2026.158832_bib0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153943","article-title":"SCF-SKP2 E3 ubiquitin ligase links mTORC1\/ER stress\/ISR with YAP activation in murine renal cystogenesis","volume":"132","author":"Panda","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.phymed.2026.158832_bib0101","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131102","article-title":"Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis","volume":"4","author":"Price","year":"2019","journal-title":"JCI. Insight"},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0102","article-title":"Dock5 Deficiency promotes proteinuric kidney diseases via modulating podocyte lipid metabolism","volume":"11","author":"Qu","year":"2024","journal-title":"Adv. Sci.)"},{"issue":"12","key":"10.1016\/j.phymed.2026.158832_bib0103","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200279","article-title":"Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity","volume":"134","author":"Querfeld","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114465","article-title":"The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects","volume":"161","author":"Ren","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2026.158832_bib0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clnesp.2021.06.006","article-title":"Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial","volume":"44","author":"Rodrigues","year":"2021","journal-title":"Clin. Nutr. ESPEN."},{"key":"10.1016\/j.phymed.2026.158832_bib0106","article-title":"Berberine reduces lipid accumulation by promoting fatty acid oxidation in renal tubular epithelial cells of the diabetic kidney","volume":"12","author":"Rong","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158832_bib0107","doi-asserted-by":"crossref","first-page":"355","DOI":"10.34067\/KID.0004772020","article-title":"Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD","volume":"2","author":"Schaub","year":"2021","journal-title":"Kidney360"},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0108","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/ndt\/gfae097","article-title":"The biology of ferroptosis in kidney disease","volume":"39","author":"Seibt","year":"2024","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.phymed.2026.158832_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.986825","article-title":"Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK\/mTOR pathways","volume":"9","author":"Sheng","year":"2022","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jnutbio.2012.04.013","article-title":"Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats","volume":"24","author":"Soetikno","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0111","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.3390\/ijms25116223","article-title":"In vitro hypoxia\/reoxygenation induces mitochondrial cardiolipin remodeling in Human kidney cells","volume":"25","author":"Strazdauskas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101841","article-title":"Farnesoid X receptor activation protects against renal fibrosis via modulation of \u03b2-catenin signaling","volume":"79","author":"Sun","year":"2024","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0113","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000518132","article-title":"The updates of podocyte lipid metabolism in proteinuric kidney disease","volume":"7","author":"Sun","year":"2021","journal-title":"Kidney Dis."},{"issue":"8","key":"10.1016\/j.phymed.2026.158832_bib0114","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0115","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00592-025-02492-5","article-title":"FTZ alleviates lipid deposition in diabetic kidney disease by AMPK\/ACC\/SREBP signaling pathway","volume":"62","author":"Tao","year":"2025","journal-title":"Acta Diabetol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000518456","article-title":"Dyslipidemia in chronic kidney disease: contemporary concepts and future therapeutic perspectives","volume":"52","author":"Theofilis","year":"2021","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13036-022-00299-4","article-title":"Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation","volume":"16","author":"Thomas","year":"2022","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.phymed.2026.158832_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156342","article-title":"Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: recent progress and future prospects","volume":"136","author":"Tian","year":"2025","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0119","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 Inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 Inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158832_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1503711","article-title":"Lipid abnormality in diabetic kidney disease and potential treatment advancements","volume":"16","author":"Tu","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2026.158832_bib0121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Ann. N Acad. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158832_bib0122","article-title":"Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0123","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.7150\/ijbs.81892","article-title":"Emerging role of ferroptosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0124","article-title":"Diabetic kidney disease macrophage cholesterol efflux: a revolution from metabolism to immune","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0125","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.7150\/ijbs.109220","article-title":"APT1-derived depalmitoylation of CD36 alleviates diabetes-induced lipotoxicity in podocytes","volume":"21","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155991","article-title":"Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2","volume":"134","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.phymed.2026.158832_bib0127","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1002\/ptr.8298","article-title":"Astragaloside IV protects renal tubular epithelial cells against oxidative stress-induced injury by upregulating CPT1A-mediated HSD17B10 lysine succinylation in diabetic kidney disease","volume":"38","author":"Wang","year":"2024","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2026.158832_bib0128","article-title":"Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0129","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.7150\/ijbs.95216","article-title":"Lipid homeostasis in diabetic kidney disease","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158832_bib0130","article-title":"Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158832_bib0131","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.552483","article-title":"High glucose aggravates cholesterol accumulation in glomerular endothelial cells through the LXRs\/LncRNAOR13C9\/ABCA1 Regulatory network","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phymed.2026.158832_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.927329","article-title":"Molecular mechanisms underlying the role of hypoxia-inducible factor-1 \u03b1 in metabolic reprogramming in renal fibrosis","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2026.158832_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1708809","article-title":"Traditional Chinese medicine monomers: a new strategy against diabetic kidney disease by regulating cholesterol efflux","volume":"12","author":"Wu","year":"2025","journal-title":"Front. Nutr."},{"issue":"7","key":"10.1016\/j.phymed.2026.158832_bib0134","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41419-023-05905-x","article-title":"Research progress on endoplasmic reticulum homeostasis in kidney diseases","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"11","key":"10.1016\/j.phymed.2026.158832_bib0135","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41419-021-04271-w","article-title":"Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"4","key":"10.1016\/j.phymed.2026.158832_bib0136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-023-05786-0","article-title":"Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"7","key":"10.1016\/j.phymed.2026.158832_bib0137","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1080\/15548627.2020.1782034","article-title":"Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux","volume":"17","author":"Yamamoto","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2026.158832_bib0138","doi-asserted-by":"crossref","DOI":"10.3389\/fceld.2025.1669955","article-title":"Lysosomal membrane-permeabilization (LMP) and -rupture (LMR) are distinct for cell death","volume":"4","author":"Yamashima","year":"2025","journal-title":"Front. Cell Death."},{"key":"10.1016\/j.phymed.2026.158832_bib0139","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1017387","article-title":"Lipid droplet - mitochondria coupling: a novel lipid metabolism regulatory hub in diabetic nephropathy","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrin."},{"issue":"12","key":"10.1016\/j.phymed.2026.158832_bib0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0141","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.phymed.2026.158832_bib0142","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1152\/ajprenal.00266.2023","article-title":"Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression","volume":"326","author":"Youssef","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105145","article-title":"cGAS-STING activation contributes to podocyte injury in diabetic kidney disease","volume":"25","author":"Zang","year":"2022","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0144","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41556-022-00894-z","article-title":"A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158832_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156354","article-title":"Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy","volume":"171","author":"Zhang","year":"2025","journal-title":"Metabolism"},{"issue":"46","key":"10.1016\/j.phymed.2026.158832_bib0146","doi-asserted-by":"crossref","first-page":"75659","DOI":"10.18632\/oncotarget.12318","article-title":"Curcumin targets the TFEB-lysosome pathway for induction of autophagy","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2026.158832_bib0147","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155377","article-title":"ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease","volume":"139","author":"Zhang","year":"2023","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.phymed.2026.158832_bib0148","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.7150\/ijbs.69618","article-title":"Dissection of targeting molecular mechanisms of aristolochic acid-induced nephrotoxicity via a combined deconvolution strategy of chemoproteomics and metabolomics","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158832_bib0149","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41620","article-title":"Lipidomics-based natural products for chronic kidney disease treatment","volume":"11","author":"Zhang","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.phymed.2026.158832_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phymed.2018.12.045","article-title":"Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2\/3-mediated profibrosis","volume":"57","author":"Zhang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158832_bib0151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41420-020-0265-4","article-title":"Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases","volume":"6","author":"Zhang","year":"2020","journal-title":"Cell Death. Discov."},{"issue":"10","key":"10.1016\/j.phymed.2026.158832_bib0152","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2741\/4885","article-title":"Resveratrol improves lipid metabolism in diabetic nephropathy rats","volume":"25","author":"Zhao","year":"2020","journal-title":"Front. Biosci."},{"key":"10.1016\/j.phymed.2026.158832_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110711","article-title":"Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB\/TNF-a\/SREBP1c signaling pathway","volume":"385","author":"Zhu","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2026.158832_bib0154","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155724","article-title":"CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease","volume":"150","author":"Zuo","year":"2024","journal-title":"Metabolism"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:59:12Z","timestamp":1791064752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326010615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":154,"alternative-id":["S0944711326010615"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158832","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting renal lipotoxicity with natural products in chronic kidney disease: mechanisms, molecular targets, and translational prospects","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158832"}}